← Leaderboards
John J McGuire
Roswell Park Cancer Institute Corp
$1,949,782
Attributed
$1,949,782
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $309.5K · FY2006–09$500K$375K$250K$125K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$1,949,782 · 2
By mechanism
R01$1,949,782 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Methotrexate”
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Norman Wolmark · Nsabp Foundation, Inc.$52,338,276
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Mary V. Relling · St. Jude Children'S Research Hospital$14,849,481
- Janet T. Holbrook · Johns Hopkins University$12,837,055
- Keri, Hammel · The Emmes Company, Llc$11,064,901
Research focus
MethotrexateLeukemiaDesignCytotoxicAcuteAntineoplasticsAcadesineChildhood LeukemiaBlast CellAdult-Amp-Activated Protein KinaseCell LineCellsChemosensitizationChildhoodBaseChildhood OsteosarcomaBiochemicalClinical ProtocolsClinical ResearchClinical TrialsCardiacCytoplasm5&Apos
Grant awards (7)
Enhancement of methotrexate uptake in childhood ALL$309,483
R01 · FY2009 · CA · contact PI
Enhancement of methotrexate uptake in childhood ALL$305,489
R01 · FY2008 · CA · contact PI
Enhancement of methotrexate uptake in childhood ALL$301,612
R01 · FY2007 · CA · contact PI
Enhancement of methotrexate uptake in childhood ALL$306,742
R01 · FY2006 · CA · contact PI
FOLYLPOLYGLUTAMATE SYNTHETASE IN CANCER CHEMOTHERAPY$245,334
R01 · FY2003 · CA
FOLYLPOLYGLUTAMATE SYNTHETASE IN CANCER CHEMOTHERAPY$242,121
R01 · FY2002 · CA
FOLYLPOLYGLUTAMATE SYNTHETASE IN CANCER CHEMOTHERAPY$239,001
R01 · FY2001 · CA